Ghia, P., Barr, P. M., Allan, J. N., Siddiqi, T., Tedeschi, A., Kipps, T. J., O'Brien, S. M., Jacobs, R., Badoux, X. C. A., Trentin, L., Lasica, M., Carney, D., Camburn, A. E., Torroba, J. D. L. S., Szafer-Glusman, E., Zhou, C., Neuenburg, J. K., Dean, J. P., Wierda, W. G., Tam, C. S. L. (2025). Final analysis of fixed-duration ibrutinib + venetoclax for chronic lymphocytic leukemia (CLL)/small lymphocytic lymphoma (SLL) in the phase 2 CAPTIVATE study.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2025.43.16_suppl.7036